Phase 1 H Syndrome Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Lynch Syndrome
Fundacion Clinic per a la Recerca Biomédica20 enrolled1 locationNCT07163403
Recruiting
Phase 1Phase 2
Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
National University of Natural Medicine32 enrolled1 locationNCT06721884
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Cushing SyndromeCushing DiseaseEctopic ACTH Syndrome
Crinetics Pharmaceuticals Inc.18 enrolled1 locationNCT05804669
Recruiting
Phase 1
5 year study of 6 children each year with vascular anomalies who have severe complications failing to respond to the usual treatments will be offered a new use of an old medication- sirolimus
PIKC3A related overgrowth syndrome (PROS)Vascular tumours (tufted angiomas and kaposiform haemangioendotheliomas)Complex lymphatic malformations+2 more
Sydney Children's Hospital, Randwick30 enrolled1 locationACTRN12616000943448